Macrogenics (MGNX) Misses Q2 EPS by 11c, Misses on Revenue
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Join SI Premium – FREE
Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.57), $0.11 worse than the analyst estimate of ($0.46). Revenue for the quarter came in at $22.2 million versus the consensus estimate of $28.06 million.
For earnings history and earnings-related data on Macrogenics (MGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi downgrades Abercrombie & Fitch to neutral after 36% stock surge
- Materialise NV (MTLS) Reports Q2 EPS of EUR0.06
- Cmb.Tech NV (CMBT) Tops Q2 EPS by 38c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
